| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
70,932,000 |
| Market
Cap: |
2.85(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$15.81 - $52.44 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company focused on changing the paradigm for the treatment of rare genetic diseases of obesity, which are characterized by early-onset, severe obesity and hyperphagia, a pathological and insatiable hunger. Co. is developing IMCIVREE™ (setmelanotide) as a medicine strategy for a subset of individuals who have severe obesity due to genetic variants that impair the melanocortin-4 receptor pathway, a pathway in the brain that is responsible for regulating hunger, caloric intake and energy expenditure, which consequently affect body weight.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
171,413 |
357,434 |
386,701 |
425,485 |
| Total Sell Value |
$6,861,691 |
$14,691,044 |
$15,456,647 |
$16,295,598 |
| Total People Sold |
7 |
7 |
7 |
8 |
| Total Sell Transactions |
20 |
34 |
41 |
60 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Orbimed Capital Gp V Llc |
10% Owner |
– – • |
2018-05-18 |
4 |
S |
$30.77 |
$2,127,315 |
I/I |
(69,136) |
2,832,159 |
|
- |
|
| Gottesdiener Keith Michael |
C.E.O. and President |
• • – |
2018-05-09 |
4 |
OE |
$4.59 |
$13,770 |
D/D |
3,000 |
588,539 |
|
- |
|
| Exter Neil |
Director |
– • – |
2017-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
0 |
|
- |
|
| Tepper Robert I |
10% Owner |
– – • |
2017-10-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,963,810 |
3,981,437 |
|
- |
|
| Foley Todd |
Director |
– • • |
2017-10-10 |
4 |
B |
$17.00 |
$1,700,000 |
I/I |
100,000 |
2,696,392 |
2.25 |
- |
|
| Foley Todd |
Director |
– • • |
2017-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
2,567,014 |
2,596,392 |
|
- |
|
| Mpm Bioventures V Llc |
10% Owner |
– – • |
2017-10-10 |
4 |
B |
$17.00 |
$1,700,000 |
I/I |
100,000 |
2,696,392 |
1.5 |
- |
|
| Mpm Bioventures V Llc |
10% Owner |
– – • |
2017-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
2,567,014 |
2,596,392 |
|
- |
|
| Mott David M |
10% Owner |
– – • |
2017-10-10 |
4 |
B |
$17.00 |
$9,350,000 |
I/I |
550,000 |
4,909,956 |
1.5 |
- |
|
| Mott David M |
10% Owner |
– – • |
2017-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
4,330,578 |
4,359,956 |
|
- |
|
| Sandell Scott D |
10% Owner |
– – • |
2017-10-10 |
4 |
B |
$17.00 |
$9,350,000 |
I/I |
550,000 |
4,909,956 |
1.5 |
- |
|
| Sandell Scott D |
10% Owner |
– – • |
2017-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
4,330,578 |
4,359,956 |
|
- |
|
| Barris Peter J |
10% Owner |
– – • |
2017-10-10 |
4 |
B |
$17.00 |
$9,350,000 |
I/I |
550,000 |
4,909,956 |
1.5 |
- |
|
| Barris Peter J |
10% Owner |
– – • |
2017-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
4,330,578 |
4,359,956 |
|
- |
|
| Baskett Forest |
10% Owner |
– – • |
2017-10-10 |
4 |
B |
$17.00 |
$9,350,000 |
I/I |
550,000 |
4,909,956 |
1.5 |
- |
|
| Baskett Forest |
10% Owner |
– – • |
2017-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
4,330,578 |
4,359,956 |
|
- |
|
| Nea 13 Gp, Ltd |
10% Owner |
– – • |
2017-10-10 |
4 |
B |
$17.00 |
$9,350,000 |
D/D |
550,000 |
4,909,956 |
2.45 |
- |
|
| Nea 13 Gp, Ltd |
10% Owner |
– – • |
2017-10-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,330,578 |
4,359,956 |
|
- |
|
| Kerins Patrick J |
10% Owner |
– – • |
2017-10-10 |
4 |
B |
$17.00 |
$9,350,000 |
I/I |
550,000 |
4,909,956 |
1.5 |
- |
|
| Kerins Patrick J |
10% Owner |
– – • |
2017-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
4,330,578 |
4,359,956 |
|
- |
|
| Barrett M James |
10% Owner |
– – • |
2017-10-10 |
4 |
B |
$17.00 |
$9,350,000 |
I/I |
550,000 |
4,909,956 |
1.5 |
- |
|
| Barrett M James |
10% Owner |
– – • |
2017-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
4,330,578 |
4,359,956 |
|
- |
|
| Viswanathan Ravi |
10% Owner |
– – • |
2017-10-10 |
4 |
B |
$17.00 |
$9,350,000 |
I/I |
550,000 |
4,909,956 |
1.5 |
- |
|
| Viswanathan Ravi |
10% Owner |
– – • |
2017-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
4,330,578 |
4,359,956 |
|
- |
|
| Deerfield Private Design Fund Iii, L.p. |
Possible Member of 10% Group |
– – • |
2017-10-10 |
4 |
B |
$17.00 |
$6,035,000 |
I/I |
355,000 |
468,505 |
1.5 |
- |
|
253 Records found
|
|
Page 10 of 11 |
|
|
1.06 (2.71%) 
